Mapping a New Universe of Medicine
Octant merges next-generation biology, chemistry, and computation to engineer precision small molecule therapeutics targeting complex cellular mechanisms that cause disease, with a focus on protein misfolding correctors. The platform enables high-throughput design, build, test, learn cycles. Pipeline includes programs for RHO-adRP (Phase 1), Fabry disease, neurodegeneration, oncology, metabolism, and immunology.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Jun 2025
Apr 2022
May 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
